177 Lu-FAP-2286 Therapy in a Metastatic Bone Malignant Solitary Fibrous Tumor.

Hongyu Yang,Huipan Liu, Hongmei Li,Yu Zhang,Yue Chen

CLINICAL NUCLEAR MEDICINE（2024）

引用 0|浏览3

暂无评分

摘要

A 57-year-old woman with a metastatic bone malignant solitary fibrous tumor received Lu-177-FAP-2286 therapy. After 1 treatment cycle, Ga-68-FAP-2286 PET/CT revealed remission of the lesions. Moreover, the patient did not report any adverse effects.

查看译文

关键词

fibroblast activation protein,Lu-177-FAP-2286,radionuclide therapy,parietal bone,malignant solitary fibrous tumor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要